Acute encephalopathy associated with continuous vincristine sulfate combination therapy: case report
- 1 September 1985
- journal article
- case report
- Published by Springer Nature in Investigational New Drugs
- Vol. 3 (3) , 315-318
- https://doi.org/10.1007/bf00179439
Abstract
Neurotoxicity is a well-recognized and commonly observed side effect associated with the use of vincristine sulfate in cancer chemotherapy. The clinical manifestations of vincristine neuropathy cover a wide spectrum of peripheral neurologic dysfunctions that have been described to be reversible and cumulative in most instances (1, 2). Paresthesias, loss of tendon reflexes, and progressive weakness are the most common clinical features (3, 4). Sensory impairment, cranial nerve palsies, gastrointestinal disturbances, and autonomie dysfunctions including atonic bladder, impotence, and orthostatic hypotension may occur (5). Acute CNS complications, usually presenting as generalized seizures, are extremely rare and only a few cases have been reported which were without underlying biochemical or structural abnormalities (1, 5–9). We describe the case of a woman with multiple myeloma, who developed fulminant encephalopathy following 4 days of continuous vincristine, adriamycin, and day 1–4 pulse dexamethasone (VAD) combination therapy.Keywords
This publication has 20 references indexed in Scilit:
- Unilateral Seizures following Vincristine Intravenous InjectionTumori Journal, 1984
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- Neurotoxicity of Commonly Used Antineoplastic AgentsNew England Journal of Medicine, 1974
- Seizures associated with vincristine sulfate therapyThe Journal of Pediatrics, 1973
- Vincristine Neurotoxicity (Cont.)New England Journal of Medicine, 1972
- Syndrome of inappropriate secretion of antidiuretic hormone produced by vincristine toxicity (with bioassay of ADH level)The Journal of Pediatrics, 1972
- The neuromyopathy of vincristine in manJournal of the Neurological Sciences, 1970
- Vincristine and Prednisone for the Induction of Remissions in Acute Childhood LeukaemiaBMJ, 1969
- Neurofibrillary DegenerationArchives of Neurology, 1969
- Hyponatremia and Vincristine TherapyAmerican Journal of Diseases of Children, 1966